全文获取类型
收费全文 | 5885篇 |
免费 | 305篇 |
国内免费 | 124篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 58篇 |
妇产科学 | 73篇 |
基础医学 | 329篇 |
口腔科学 | 9篇 |
临床医学 | 832篇 |
内科学 | 2450篇 |
皮肤病学 | 16篇 |
神经病学 | 158篇 |
特种医学 | 220篇 |
外科学 | 482篇 |
综合类 | 786篇 |
预防医学 | 127篇 |
眼科学 | 7篇 |
药学 | 433篇 |
1篇 | |
中国医学 | 262篇 |
肿瘤学 | 61篇 |
出版年
2024年 | 10篇 |
2023年 | 154篇 |
2022年 | 264篇 |
2021年 | 353篇 |
2020年 | 294篇 |
2019年 | 345篇 |
2018年 | 296篇 |
2017年 | 131篇 |
2016年 | 102篇 |
2015年 | 118篇 |
2014年 | 334篇 |
2013年 | 256篇 |
2012年 | 197篇 |
2011年 | 223篇 |
2010年 | 198篇 |
2009年 | 191篇 |
2008年 | 220篇 |
2007年 | 273篇 |
2006年 | 237篇 |
2005年 | 211篇 |
2004年 | 154篇 |
2003年 | 200篇 |
2002年 | 178篇 |
2001年 | 182篇 |
2000年 | 159篇 |
1999年 | 179篇 |
1998年 | 159篇 |
1997年 | 96篇 |
1996年 | 73篇 |
1995年 | 59篇 |
1994年 | 66篇 |
1993年 | 49篇 |
1992年 | 48篇 |
1991年 | 33篇 |
1990年 | 27篇 |
1989年 | 21篇 |
1988年 | 21篇 |
1987年 | 21篇 |
1986年 | 25篇 |
1985年 | 26篇 |
1984年 | 33篇 |
1983年 | 14篇 |
1982年 | 20篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1977年 | 3篇 |
1975年 | 4篇 |
1974年 | 4篇 |
排序方式: 共有6314条查询结果,搜索用时 15 毫秒
11.
不稳定型心绞痛患者内皮素及血管性假血友病因子的改变 总被引:2,自引:0,他引:2
目的 观察不稳定型心绞痛 (Unstableanginapectoris,UAP)患者内皮素 (Endothelin,ET)及血管性假血友病因子 (vonWillebrandfactor,vWF)的变化。方法 不稳定型心绞痛患者34例、正常人21名分别在清晨采血测定ET及vWF值。 结果 不稳定型心绞痛患者ET(129.3±26.4) pg/ml及vWF(185.4±32.4) %值明显高于正常人(85.2±39.6)pg/ml及(142.1±42.0) % ,两者之间不具有显著相关性 (r=0.15,P>0.05)。结论 ET及vWF的改变可能参与了不稳定型心绞痛的病理生理过程。 相似文献
12.
两种艾灸法对二肾一夹型高血压大鼠血压和血管内皮细胞内分泌功能的影响 总被引:4,自引:0,他引:4
目的:应用两种艾灸疗法治疗两肾一夹肾血管性高血压大鼠(2K1C-RHR),评价这两种艾灸疗法的降压作用,并对其降压机理作初步的探讨。方法:建立2K1C-RHR模型,并将其随机分为六组:灸法Ⅰ组(百会、神阙、足三里)、灸法Ⅱ组(关元、涌泉、足三里)、卡托普利组、灸法Ⅰ+卡托普利组、灸法Ⅱ+卡托普利组、高血压对照组,另设正常对照组。经过10天治疗后,测量血压,并测定血浆中内皮素(ET)、一氧化氮(NO)。结果:高血压对照组的收缩压(SBP)、舒张压(DBP)明显高于正常对照组,各治疗组的SBP、DBP明显低于高血压对照组(P<0.01),各治疗组间则没有明显差异(P>0.05)。血浆NO含量各组间没有明显差异(P>0.05)。各治疗组与正常对照组的血浆中ET含量明显低于高血压对照组(P<0.01)。各治疗组ET/NO比值接近正常对照组(P>0.05)且明显低于高血压对照组(P>0.05)。结论:两种艾灸疗法有良好的降压作用,其降压机理与及纠正ET与NO的失衡状态有关。 相似文献
13.
Brigden Geoffrey Zanelli Giussepe Lahiri Avijit Raftery Edward 《European journal of nuclear medicine and molecular imaging》1990,16(11):795-799
A new, single bolus method of in vivo blood pool imaging using a technetium Tc99m phosphine isocyanide complex (DEPIC) which binds to pre-albumin was evaluated in volunteers (n=4) and patients (n=20). DEPIC was assessed for its safety and possible drug interactions. Its duration of action and quality of ventriculography were compared with imaging using standard in vivo red cell labelling (PYP) during two 3-h scanning periods 1 week apart. DEPIC had a mean plasma halflife of 3.3 h. The count rate over the left ventricle was initially 42% higher with DEPIC than with PYP. However, removal of DEPIC by the liver resulted in equivalent count rates by 1 h, and by 3 h PYP count rates were 22% higher than DEPIC. Immediately post injection mean (SD) difference in the left ventricular ejection fraction between the two methods was 2.4% (7.7%). Satisfactory DEPIC scans were obtained up to 2 h post injection, but by 3 h there was a mean difference of 13% (11.3%). DEPIC was found to be a safe alternative to red all labelling for blood pool angiography, suitable for routine work. The single bolus methodology and high initial count rates offer improved efficiency and a capability for truly emergency scanning. 相似文献
14.
通过42例重型肺心病、7例轻型肺心病、16例肺心病伴发冠心病患者和30例正常人在静息状态下的左右心脏射血分数及其临床资料的分析表明,重型肺心病患者在病情的急性发作期,存在有不同程度的左心功能不全,而轻型肺心病患者则无左心功能不全的表现。表明慢性肺心病仅在病程晚期,才由以右心为主的疾病发展成为全心病。本文还对重型肺心病与肺心病伴发冠心病患者的左心功能进行比较,结果表明,肺心病伴发冠心病患者左室功能受损程度更为明显,双重病因导致的左室功能减退,常造成心肌更严重的损害而且不容易恢复。 相似文献
15.
小儿肾脏疾病血,尿内皮素的变化 总被引:9,自引:0,他引:9
目的研究小儿肾脏疾病血、尿内皮素(PET、UET)的水平及其相互关系。方法采用同位素放免方法检测了肾病综合征(NS),肾小球肾炎(GN),肾功能衰竭(RF)共72例患儿血及尿中ET,血心钠素(ANP)水平。结果NS,GN,RF三组的PET及UET值明显高于对照组,尤其RF组(P<005,P<0.01)。ANP值在GN组和RF组明显高于对照组(P<001)。8例ARF患儿恢复期血ET水平下降,6例CRF患儿虽经治疗,但血ET水平不降或上升。结论ET在小儿肾脏疾病发病机理及病情进展中可能起重要作用,其值高低与病情严重程度及预后有关。 相似文献
16.
An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage 总被引:10,自引:0,他引:10
Cerebral vasospasm and the resulting cerebral ischemia occurring after subarachnoid hemorrhage (SAH) are still responsible for the considerable morbidity and mortality in patients affected by cerebral aneurysms. Mechanisms contributing to the development of vasospasm, abnormal reactivity of cerebral arteries and cerebral ischemia after SAH have been intensively investigated in recent years. It has been suggested that the pathogenesis of vasospasm is related to a number of pathological processes, including endothelial damage, smooth muscle cell contraction resulting from spasmogenic substances generated during lyses of subarachnoid blood clots, changes in vascular responsiveness and inflammatory or immunological reactions of the vascular wall.A great deal of experimental and clinical research has been conducted in an effort to find ways to prevent these complications. However, to date, the main therapeutic interventions remain elusive and are limited to the manipulation of systemic blood pressure, alteration of blood volume or viscosity, and control of arterial dioxide tension.Even though no single pharmacological agent or treatment protocol has been identified which could prevent or reverse these deadly complications, a number of promising drugs have been investigated. Among these is the hormone erythropoietin (EPO), the main regulator of erythropoiesis. It has recently been found that EPO produces a neuroprotective action during experimental SAH when its recombinant form (rHuEPO) is systemically administered.This topic review collects the relevant literature on the main investigative therapies for cerebrovascular dysfunction after aneurysmal SAH. In addition, it points out rHuEPO, which may hold promise in future clinical trials to prevent the occurrence of vasospasm and cerebral ischemia after SAH. 相似文献
17.
Bing Feng P. Hendrik Pretorius Troy H. Farncombe Seth T. Dahlberg Manoj V. Narayanan Miles N. Wernick Anna M. Celler Jeffrey A. Leppo Michael A. King 《Journal of nuclear cardiology》2006,13(3):354-361
BACKGROUND: Dynamic single photon emission computed tomography (SPECT) acquisition and reconstruction of early poststress technetium 99m teboroxime washout images has been shown to be useful in the detection of coronary disease. Assessment of poststress regional wall motion may offer additional use in assessing coronary disease. Our goal was to investigate the feasibility of simultaneously imaging myocardial ischemia and transient poststress akinesis using gated-dynamic SPECT. METHODS AND RESULTS: A gated-dynamic mathematical cardiac torso (MCAT) phantom was developed to model both teboroxime kinetics and cardiac regional wall motion. A lesion was simulated as having delayed poststress teboroxime washout together with a transient poststress wall motion abnormality. Gated projection data were created to represent a 3-headed SPECT system undergoing a total rotation of 480 degrees . The dynamic expectation-maximization reconstruction algorithm with postsmoothing across gating intervals by Wiener filtering, and the ordered-subset expectation maximization reconstruction algorithm with 3-point smoothing across gating intervals were compared. Compared with the ordered-subset expectation maximization with 3-point smoothing, the dynamic expectation-maximization algorithm with Wiener filtering was able to produce visually higher-quality images and more accurate left ventricular ejection fraction estimates. CONCLUSION: From simulations, we conclude that changing cardiac function and tracer localization possibly can be assessed by using a gated-dynamic acquisition protocol combined with a 5-dimensional reconstruction strategy. 相似文献
18.
阻塞性黄疸大鼠肾脏自分泌内皮素的变化及其与肾功能损害的关系 总被引:3,自引:1,他引:2
目的 探讨阻塞性黄疸时肾脏自分泌内皮素 (ET)的变化及其与肾功能损害的关系。方法 结扎胆总管(BDL)制备阻塞性黄疸大鼠模型 ,作为实验组 ,对照组鼠仅行假手术。分别于术后 5、1 0及 1 5d ,两组各取 1 0只大鼠检测其肾脏对氨基马尿酸清除率 (CPAH)、菊粉清除率 (CIN)和钠排泄分数 (FENa+) ,并用鲎试剂法测定血浆内毒素 (EX)水平 ,放射免疫法测定肾动、静脉血浆及肾组织中ET 1含量。结果 ①实验组术后 5d仅FENa+明显高于对照组 (P<0 .0 1 ) ,术后 1 0d起 ,CPAH、CIN及FENa+呈进行性下降 ,术后 1 5dFENa+已较对照组低 ,与对照组比较差异有显著性 (P<0 .0 1 ) ;②实验组术后血浆EX水平呈进行性升高 ,与对照组比较差异有显著性 (P<0 .0 1 ) ;③实验组术后肾动脉血浆ET 1水平呈持续性降低 ,而肾静脉血浆及肾组织中ET 1含量呈持续性升高 ,与对照组比较差异有显著性 (P<0 .0 1 ) ;④血浆EX水平与肾组织ET 1含量呈正相关 (r =0 .762 4 ,P<0 .0 1 ) ,肾组织ET 1含量与CPAH和CIN呈负相关 (r=- 0 .883 2 ,P<0 .0 1 ;r =- 0 .945 2 ,P<0 .0 1 )、与FENa+呈正相关 (r=0 .873 4 ,P<0 .0 1 )。结论 内毒素血症及其诱导的肾内ET分泌增加在阻塞性黄疸所致大鼠肾损害中可能具有重要作用 相似文献
19.
Renal excretion of endothelin in children 总被引:1,自引:0,他引:1
István Máttyus L. B. Zimmerhackl A. Schwarz M. Brandis M. Miltényi T. Tulassay 《Pediatric nephrology (Berlin, Germany)》1997,11(4):513-521
Endothelin (ET) is a peptide with profound vasoconstrictive potential. First isolated from porcine endothelial cell supernatant,
it is produced also by smooth muscle, epithelial and circulating cells. Besides vasoconstriction, a wide spectrum of biological
activities of ET (via activation of membrane receptors) has been described. These include regulation of other hormones and
neurotransmitters, cellular growth and proliferation, bronchoconstriction, and, in the kidney, natriuresis and water diuresis.
ET exerts its effects mainly in an autocrine and paracrine fashion. A high concentration of ET is found in urine, compared
with plasma originating mainly from the kidney itself. In this review we focus on the role of urinary excretion of ET in children.
ET excretion was determined under different physiological and pathological conditions. In premature infants and newborns,
the daily excretion of ET (corrected for body surface) was higher than in older children; it was constant, and comparable
to the values in healthy adults after the age of 2 years. Renal ET excretion correlated positively with urine flow in both
healthy and sick children. Conditions with tubular and/or collecting duct cell damage, such as severe hypoxia, hemolytic-uremic
syndrome, renal transplantation, diabetes mellitus, chronic renal failure, and contrast media cytotoxicity were characterized
by elevated urinary excretion of ET. In conclusion, the renal excretion of ET is influenced by several factors, probably reflecting
the intrarenal ET production. ET has a low specificity with regard to renal injury.
Received May 7, 1996; received in revised form January 14, 1997; accepted January 17, 1997 相似文献
20.
自发性高血压大鼠内皮素A型受体基因的表达 总被引:2,自引:0,他引:2
应用反转录-聚合酶链式反应(reversetranscription-polymerasechainreaction,RT-PCR)方法,测定大鼠ET-A型受体(endothelinAreceptorETA-R)mRNA在体内的分布,证明ETA-RmRNA不仅存在于血管平滑肌细胞,亦存在于内皮细胞中;而且广泛分布于脑、心、肾、肺等组织内。首次发现,在SHR大鼠的脑、心、肾组织中,ETA-RmRNA水平明显升高,提示ETA-R基因表达增加,亦可能是高血压发病的一个重要因素。 相似文献